Phage therapy may be a solution to treating infections caused by antibiotic-resistant bacteria. Since 2013, researchers at the University of Helsinki in Finland have collected bacteriophages to combat antibiotic-resistant ...
Cell & Microbiology
Nov 16, 2016
0
2
Researchers are using a natural material derived from seaweed to promote vascular cell growth, prevent blood clots and improve the performance of synthetic vascular grafts used in heart bypass surgery.
Materials Science
Dec 5, 2022
0
420
Stanford University chemist Paul Wender and his colleagues are working to improve treatments for cancer, HIV and Alzheimer's—and they are betting that a drab, weedy marine invertebrate is the means to achieving that end. ...
Biochemistry
Apr 27, 2020
0
442
Assistant Professor Alireza Dolatshahi-Pirouz and colleagues have developed a hydrogel that combines synthetic materials with living cells, and can turn stem cells into bone without adding external growth or differentiation ...
Materials Science
Feb 27, 2019
0
77
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Materials Science
Mar 26, 2021
0
22
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.
Bio & Medicine
Jun 13, 2011
1
1
Clinical trials of new drugs or devices face a problem that most empirical inquiries don't: They must not only provide clear data about toxicity and efficacy but also try to maximize the quality of treatment for all of the ...
Computer Sciences
Sep 18, 2015
0
33
(Phys.org) -- Bewildered by the array of antioxidant fruit juices on display in the supermarket and the promises they make? To sort out the antioxidant properties of fruits and berries, scientists at Emory University School ...
Cell & Microbiology
Aug 21, 2012
0
0
Compounds containing metals could hold the key to the next generation of antibiotics to combat the growing threat of global antibiotic resistance.
Cell & Microbiology
Feb 27, 2020
0
88
A senior researcher who can't get an answer from a shutdown NIH about a proposed clinical trial on a neurodegenerative disease, a Nobel Prize-winning scientist who fears that a generation of innovators will be lost, and a ...
Other
Oct 8, 2013
0
0
